Apollo Stent for Symptomatic Atherosclerotic Intracranial Stenosis: Study Results

References

1. ↵
   Wong KS, Li H, Lam WWM, et al. Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke. Stroke 2002;33:532–36

   Abstract/FREE Full Text
2. ↵
   Prognosis of patients with symptomatic vertebral or basilar artery stenosis: the Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Stroke 1998;29:1389–92

   Abstract/FREE Full Text
3. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000;55:490–97

   Abstract/FREE Full Text
4. Kern R, Steinke W, Daffertshofer M, et al. Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease. Neurology 2005;65:859–64

   Abstract/FREE Full Text
5. ↵
   Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–16

   CrossRefPubMedWeb of Science
6. ↵
   Schumacher HC, Khaw AV, Meyers PM, et al. Intracranial revascularization therapy: angioplasty and stenting. Curr Treat Options Cardiovasc Med 2004;6:193–98

   PubMed
7. ↵
   Hartmann M, Jansen O. Angioplasty and stenting of intracranial stenosis. Curr Opin Neurol 2005;18:39–45

   PubMedWeb of Science
8. ↵
   Mori T, Kazita K, Chokyu K, et al. Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol 2000;21:249–54

   Abstract/FREE Full Text
9. Lylyk P, Cohen JE, Ceratto R, et al. Angioplasty and stent placement in intracranial atherosclerotic stenoses and dissections. AJNR Am J Neuroradiol 2002;23:430–36

   Abstract/FREE Full Text
10. Jiang WJ, Wang YJ, Du B, et al. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke 2004;35:1375–80

    Abstract/FREE Full Text
11. Kim DJ, Lee BH, Kim DI, et al. Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results. AJNR Am J Neuroradiol 2005;26:1381–88

    Abstract/FREE Full Text
12. Du Mesnil de Rochemont R, Turowski B, Buchkremer M, et al. Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of under-sized stents: initial experience. Radiology 2004;231:45–49

    PubMedWeb of Science
13. ↵
    Yu W, Smith WS, Singh V, et al. Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology 2005;64:1055–57

    Abstract/FREE Full Text
14. Marks MP, Marcellus M, Norbash AM, et al. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999;30:1065–69

    Abstract/FREE Full Text
15. ↵
    SSYLVIA Study Investigators. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA). Stroke 2004;35:1388–92. Epub 2004 Apr 22

    Abstract/FREE Full Text
16. ↵
    Henkes H, Miloslavskil E, Lowens S, et al. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 2005;47:222–28

    CrossRefPubMedWeb of Science
17. ↵
    Coull AJ, Rothwell PM. Underestimation of the early risk of recurrent stroke: evidence of the need for a standard definition. Stroke 2004;35:1925–29

    Abstract/FREE Full Text
18. ↵
    Morgenstern LB, Lisabeth LD, Mecozzi AC, et al. A population-based study of acute stroke and TIA diagnosis. Neurology 2004;62:895–900

    Abstract/FREE Full Text
19. ↵
    Samuels OB, Joseph JJ, Lynn MJ, et al. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000;21:643–46

    Abstract/FREE Full Text
20. ↵
    Tardif JC, Cote G, Lesperance J, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty: Multivitamins and Probucol Study Group. N Eng J Med 1997;337:365–72

    CrossRefPubMedWeb of Science
21. ↵
    Rodes J, Cote G, Lesperance J, et al. Prevention of restenosis after angioplasty in small coronary arteries with probucol. Circulation 1998;97:429–36

    Abstract/FREE Full Text
22. ↵
    Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update—Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002;106:388–91

    FREE Full Text
23. ↵
    Jiang WJ, Du B, Leung TW, et al. Symptomatic intracranial stenosis: cerebrovascular complications from elective stent placement. Radiology 2007;243:188–97

    CrossRefPubMedWeb of Science
24. ↵
    Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555–63

    Abstract/FREE Full Text
25. ↵
    Takis C, Kwan ES, Pessin MS, et al. Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol 1997;18:1661–68

    Abstract
26. ↵
    Masuo O, Terada T, Walker G, et al. Patency of perforating arteries after stent placement? A study using an in vivo experimental atherosclerosis-induced model. AJNR Am J Neuroradiol 2005;26:543–48

    Abstract/FREE Full Text
27. ↵
    Jiang WJ, Srivastava T, Gao F, et al. Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 2006;66:186–72